The proceedings of the 1st International Babylon Conference on Clinical and Experimental Pharmacological Research (taking place at the College of Pharmacy of the University of Babylon, in Hillah, Iraq; May 4-5, 2024) are hereby hosted by the Review of Clinical Pharmacology and Pharmacokinetics – International Edition; a journal that has provided a significant service to the international pharmacological community since 1987. These proceedings include a total of 50 papers (including this editorial) and provide a representative overview of the conference’s rich scientific pro¬gramme. The latter has served two objectives: (i) to facilitate the mapping of the Iraqi pharmacological research and priorities, and (ii) to enable the establishment of international collaborations in the field. In that respect, the proceed¬ings host the inspiring messages of several conference keynote speakers from abroad, and feature a variety of clinical and experimental studies that well relate to the priorities currently set by the Iraqi pharmacological community.
No takes yet. Share an insight, caveat, or question.
Liapi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: